PULMONX CORPORATION Share-based Payment Arrangement, Expense
PULMONX CORPORATION (LUNG) reported Share-based Payment Arrangement, Expense of $3.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-04
- PULMONX CORPORATION share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.70M, a 40.49% decline year-over-year.
- PULMONX CORPORATION share-based payment arrangement, expense for the quarter ending 2026-03-31 was $4.14M, a 26.30% decline year-over-year.
- PULMONX CORPORATION share-based payment arrangement, expense for the quarter ending 2025-12-31 was $4.24M, a 23.21% decline year-over-year.
- PULMONX CORPORATION share-based payment arrangement, expense for the quarter ending 2025-09-30 was $5.17M, a 11.53% decline year-over-year.
- PULMONX CORPORATION share-based payment arrangement, expense for fiscal 2025 was $21.23M, a 7.50% decline from fiscal 2024.
- PULMONX CORPORATION share-based payment arrangement, expense for fiscal 2024 was $22.95M, a 3.86% increase from fiscal 2023.
- PULMONX CORPORATION share-based payment arrangement, expense for fiscal 2023 was $22.10M, a 34.39% increase from fiscal 2022.
- PULMONX CORPORATION share-based payment arrangement, expense for fiscal 2022 was $16.45M, a 56.17% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.70M 10-Q · filed 2026-08-04 | $7.83M 10-Q · filed 2026-08-04 | $12.07M derived: sum of 3 quarters · filed 2026-08-04 | $17.24M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $4.14M 10-Q · filed 2026-05-04 | $8.38M derived: sum of 2 quarters · filed 2026-05-04 | $13.54M derived: sum of 3 quarters · filed 2026-05-04 | $19.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $9.41M derived: sum of 2 quarters · filed 2026-03-10 | $15.62M derived: sum of 3 quarters · filed 2026-08-04 | $21.23M 10-K · filed 2026-03-10 |
| 2025-09-30 | $5.17M 10-Q · filed 2025-11-12 | $11.38M derived: sum of 2 quarters · filed 2026-08-04 | $16.99M 10-Q · filed 2025-11-12 | $22.52M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $6.21M 10-Q · filed 2026-08-04 | $11.83M 10-Q · filed 2026-08-04 | $17.35M derived: sum of 3 quarters · filed 2026-08-04 | $23.19M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $5.61M 10-Q · filed 2026-05-04 | $11.13M derived: sum of 2 quarters · filed 2026-05-04 | $16.97M derived: sum of 3 quarters · filed 2026-05-04 | $22.89M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $11.36M derived: sum of 2 quarters · filed 2026-03-10 | $17.28M derived: sum of 3 quarters · filed 2026-03-10 | $22.95M 10-K · filed 2026-03-10 |
| 2024-09-30 | $5.84M 10-Q · filed 2025-11-12 | $11.76M derived: sum of 2 quarters · filed 2025-11-12 | $17.43M 10-Q · filed 2025-11-12 | $23.03M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $5.92M 10-Q · filed 2025-08-01 | $11.59M 10-Q · filed 2025-08-01 | $17.19M derived: sum of 3 quarters · filed 2025-08-01 | $23.19M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $5.67M 10-Q · filed 2025-05-02 | $11.27M derived: sum of 2 quarters · filed 2025-05-02 | $17.27M derived: sum of 3 quarters · filed 2025-05-02 | $23.14M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $11.60M derived: sum of 2 quarters · filed 2025-02-25 | $17.46M derived: sum of 3 quarters · filed 2025-02-25 | $22.10M 10-K · filed 2025-02-25 |
| 2023-09-30 | $6.00M 10-Q · filed 2024-11-01 | $11.87M derived: sum of 2 quarters · filed 2024-11-01 | $16.50M 10-Q · filed 2024-11-01 | $20.75M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $5.86M 10-Q · filed 2024-08-02 | $10.50M 10-Q · filed 2024-08-02 | $14.75M derived: sum of 3 quarters · filed 2024-08-02 | $19.05M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $4.64M 10-Q · filed 2024-05-03 | $8.88M derived: sum of 2 quarters · filed 2024-05-03 | $13.19M derived: sum of 3 quarters · filed 2024-05-03 | $17.57M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $8.55M derived: sum of 2 quarters · filed 2024-02-27 | $12.93M derived: sum of 3 quarters · filed 2024-02-27 | $16.45M 10-K · filed 2024-02-27 |
| 2022-09-30 | $4.30M 10-Q · filed 2023-11-03 | $8.69M derived: sum of 2 quarters · filed 2023-11-03 | $12.20M 10-Q · filed 2023-11-03 | $15.21M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $4.38M 10-Q · filed 2023-08-04 | $7.90M 10-Q · filed 2023-08-04 | $10.91M derived: sum of 3 quarters · filed 2023-08-04 | $13.85M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $3.51M 10-Q · filed 2023-05-08 | $6.53M derived: sum of 2 quarters · filed 2023-05-08 | $9.46M derived: sum of 3 quarters · filed 2023-05-08 | $11.78M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $5.95M derived: sum of 2 quarters · filed 2023-03-01 | $8.26M derived: sum of 3 quarters · filed 2023-03-01 | $10.53M 10-K · filed 2023-03-01 |
| 2021-09-30 | $2.94M 10-Q · filed 2022-11-08 | $5.25M derived: sum of 2 quarters · filed 2022-11-08 | $7.52M 10-Q · filed 2022-11-08 | $9.83M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $2.31M 10-Q · filed 2022-08-08 | $4.58M 10-Q · filed 2022-08-08 | $6.89M derived: sum of 3 quarters · filed 2022-08-08 | $7.41M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $2.27M 10-Q · filed 2022-05-09 | $4.58M derived: sum of 2 quarters · filed 2022-05-09 | $5.10M derived: sum of 3 quarters · filed 2022-05-09 | $5.26M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.83M derived: sum of 2 quarters · filed 2022-03-01 | $2.99M derived: sum of 3 quarters · filed 2022-03-01 | $3.20M 10-K · filed 2022-03-01 |
| 2020-09-30 | $518.00K 10-Q · filed 2021-11-09 | $677.00K derived: sum of 2 quarters · filed 2021-11-09 | $886.00K 10-Q · filed 2021-11-09 | $1.05M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $159.00K 10-Q · filed 2021-08-10 | $368.00K 10-Q · filed 2021-08-10 | $535.00K derived: sum of 3 quarters · filed 2021-08-10 | $607.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $209.00K 10-Q · filed 2021-05-12 | $376.00K derived: sum of 2 quarters · filed 2021-05-12 | $448.00K derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $239.00K derived: sum of 2 quarters · filed 2021-03-15 | $364.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $72.00K 10-Q · filed 2020-11-13 | $197.00K 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | $366.00K 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |